Myeloma cell expression of candidate genes for osteolytic bone disease - Over-expression of DKK1 correlates with clinical bone involvment.

被引:0
|
作者
Haaber, Jacob
Knudsen, Lene M.
Dahl, Inger M.
Abildgaard, Niels
Lodahl, Marianne
Rasmussen, Thomas
机构
[1] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark
[2] Univ Copenhagen, Dept Haematol, Copenhagen, Denmark
[3] Univ Tromso Hosp, Dept Haematol, N-9012 Tromso, Norway
关键词
D O I
10.1182/blood.V108.11.3406.3406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3406
引用
收藏
页码:973A / 973A
页数:1
相关论文
共 50 条
  • [21] Inhibiting dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, Debby
    Chantry, Andrew
    Buckle, Clive
    Coulton, Les
    Shaughnessy, John, Jr.
    Evans, Holly
    Stover, David
    Vanderkerken, Karin
    Croucher, Peter
    CANCER TREATMENT REVIEWS, 2008, 34 : S52 - S52
  • [22] Multiple myeloma cells cross talk with bone marrow stroma lead to induction of DKK1 expression and produce bortezomib resistance
    Ryu, Jiyeon
    Jung, Woo-june
    Lee, Chansu
    Park, Soyoung
    Park, Juwon
    Bae, Eunkyung
    Ahn, Kwang-Sung
    Yoon, Sung-Soo
    CANCER RESEARCH, 2012, 72
  • [23] Expression of DKK1, HGF, FRP-B, and Syndecan1 in Bone Biopsies from MM Patients Correlates with OBD
    Abildgaard, N.
    Haaber, J.
    Andersen, T.
    Pallisgaard, N.
    Kerndrup, G.
    Petersen, M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S142 - S142
  • [24] Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases
    Mariz Kasoha
    Rainer M. Bohle
    Anita Seibold
    Christoph Gerlinger
    Ingolf Juhasz-Böss
    Erich-Franz Solomayer
    Clinical & Experimental Metastasis, 2018, 35 : 763 - 775
  • [25] Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases
    Kasoha, Mariz
    Bohle, Rainer M.
    Seibold, Anita
    Gerlinger, Christoph
    Juhasz-Boess, Ingolf
    Solomayer, Erich-Franz
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (08) : 763 - 775
  • [26] Silencing Dkk1 expression rescues dexamethasone-induced bone loss in vitro.
    Butler, J. S.
    Hurson, C. J.
    Moon, R. T.
    O'Byrne, J. M.
    Doran, P. P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S145 - S145
  • [27] Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma
    Kristensen, Ida Bruun
    Haaber, Jacob
    Lyng, Maria B.
    Pedersen, Lise
    Rasmussen, Lars Melholt
    Ditzel, Henrik J.
    Abildgaard, Niels
    BLOOD, 2012, 120 (21)
  • [28] CONSEQUENCES OF HIF1A OVER-EXPRESSION IN RENAL CELL CARCINOMA AND BONE METASTASES
    Szendroi, A.
    Szasz, A. M.
    Kardos, M.
    Tokes, A. M.
    Idan, R.
    Romics, I
    Szendroi, M.
    Timar, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 236 - 236
  • [29] Dkk1 disrups Wnt signaling regulated Opg/rankl axis in osteoblast progenitors, a potential mechanism of myeloma triggered osteolytic bone lesion
    Qiang, Y.
    Brown, N.
    Chen, Y.
    Barlogie, B.
    Shaughnessy, J., Jr.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 63 - 63
  • [30] Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis
    Kristensen, Ida Bruun
    Haaber, Jacob
    Lyng, Maria Bibi
    Knudsen, Lene Meldgaard
    Rasmussen, Thomas
    Ditzel, Henrik Jorn
    Abildgaard, Niels
    LEUKEMIA & LYMPHOMA, 2013, 54 (02) : 425 - 427